Abstract
Chronic treatments with antidepressants active on major depressive disorders influence pathways involved in cell survival and plasticity. As astrocytes seem to play a key role in the protection of brain cells, we investigated in these cells the rapid effects of the antidepressant fluoxetine (Prozac®) on signaling cascades and gene induction, which probably play a role in neuroprotection. We show here that fluoxetine alone activates the extracellular signal-regulated-protein kinase (Erk) and p38 mitogen-associated protein (MAP) kinase cascades. RT-PCR revealed that genes, modulated in brain by long-term fluoxetine treatment, are rapidly induced (detectable after 2–4 h) by fluoxetine in cultured astrocytes: brain-derived nerve factor (BDNF) and its receptors, glialderived nerve factor (GDNF) and deiodinase 3 (D3). Induction of D3 by fluoxetine is inhibited by U0126 and SB203580, suggesting that Erk and p38 MAP kinases are involved. Glial-derived nerve factor (GDNF) induction by fluoxetine is prevented by U0126, suggesting that Erk is implicated. Brain-derived nerve factor (BDNF) induction seems mediated by other signaling pathways. In conclusion, we show that fluoxetine alone rapidly activates mitogen activated protein (MAP) kinase cascades in rat astrocytes and that genes involved in neuroprotection are induced in a few hours in a MAP kinase-dependent or -independent manner.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bartholoma P., Erlandson N., Kaufman K., Rössler C. G., Baumann B., Wirth T., et al. (2002) Neuronal cell death induced by antidepressants: lack of correlation with Egr-1, NF-kappa B and extracellular signal-regulated protein kinase activation. Biochem. Pharmacol. 63, 1507–1516.
Baumgartner A. (2000) Thyroxine and the treatment of affective disorders: an overview of the results of basic and clinical research. Int. J. Neuropsychopharmacology 3, 149–165.
Bayer T. A., Schramm M., Feldmann N., Knable M. B., and Falkai P. (2000) Antidepressant drug exposure is associated with mRNA levels of tyrosine receptor kinase B in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 24, 881–888.
Chakrabarti S. and Malhotra M. D. (2001) Thyroid hormones in treatment of mood disorders. Int. J. Med. Sci. 55, 501–507.
Chen A. C., Eisch A. J., Sakai N., Takahashi M., Nestler E. J., and Duman R. S. (2001) Regulation of GFR alpha-1 and GFR alpha-2 mRNAs in rat brain by electroconvulsive seizure. Synapse 39, 42–50.
Chen B., Dowlatshashi M., MacQueen G. M., Wang J. F., and Young L. T. (2001) Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry 50, 260–265.
Chen G., Huang L. D., Jiang M., and Manji H. K. (1999a) The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J. Neurochem. 72, 1327–1330.
Chen G., Masana M. I., and Manji H. K. (1999b) Lithium regulates PKC-mediated intracellular cross-talk and gene expression in the CNS in vivo. Bipolar Disord. 2, 217–236.
Chen Y., Peng L., Zhang X., Stolzenburg J. U., and Hertz L. (1995) Further evidence that fluoxetine interacts with a 5-HT2c receptor in glial cells. Brain Res. Bull. 38, 153–159.
Coppen A. (1967) The biochemistry of affective disorders. Br. J. Psychiatry 113, 1237–1264.
Courtin F., Chantoux F., and Francon J. (1986) Thyroid hormone metabolism by glial cells in culture. Mol. Cell. Endocrinol. 48, 167–178.
Daniel W. A., Wojcikowski J., and Palucha A. (2001) Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping. Br. J. Pharmacol. 134, 807–814.
D’sa C. and Duman R. S. (2002) Antidepressants and neuroplasticity. Bipolar Disord. 4, 183–184.
Duman R. S., Heninger G. R., and Nestler E. J. (1997) A molecular and cellular theory of depression. Arch. Gen. Psychiatry 54, 597–606.
Duman R. S., Malberg J., Nakagawa S., and Thome J. (2000) Neuronal plasticity and survival in mood disorders. Biol. Psychiatry 48, 732–739.
Duman R. S., Malberg J., and Thome J. (1999) Neural plasticity to stress and antidepressant treatment. Biol. Psychiatry 46, 1181–1191.
Duman R. S., Nakagawa S., and Malberg J. (2001) Regulation of adult neurogenesis by antidepressant treatment. Neuropsychopharmacology 25, 836–844.
Einat H., Yuan P., Gould T. D., Li J., Du J. H., Zhang L., et al. (2003) The role of the extracellular signal-regulated kinase signaling pathway in mood modulation. J. Neurosci. 23, 7311–7316.
Esfandiari A., Gagelin C., Gavaret J. M., Pavelka S., Lennon A., Pierre M., and Courtin F. (1994) Induction of type III-deiodinase activity in astroglial cells by retinoids. Glia 11, 255–261.
Gavaret J. M., Matricon C., Pomerance M., Jacquemin C., Toru-Delbauffe D., and Pierre M. (1989) Activation of S6 kinase in astroglial cells by FGFa and FGFb. Dev. Brain Res. 45, 77–82.
Gould E., Tanapat P., McEwen B. S., Flugge G., and Fuchs E. (1998) Proliferation of granule cell precursors in the dentategyrus of adult monkeys is diminished by stress. Proc. Natl. Acad. Sci. USA 95, 3168–3171.
Hindmarch I. (2001) Expanding the horizons of depression: beyond the monoamine hypothesis. Hum. Psychopharmacol. 16, 203–218.
Hisaoka K., Nishida A., Koda T., Miyata M., Zensho H., Morinobu S., et al. (2001) Antidepressant drug treatments induce glial cell line-derived neurotrophic factor (GDNF) synthesis and release in rat C6 gioblastoma cells. J. Neurochem. 79, 25–34.
Jing S., Wen D., Yu Y., Holst P. L., Luo Y., Fang M., et al. (1996) GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell 85, 1113–1124.
Klein P. S. and Melton D. A. (1996) A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. USA 93, 8454–8459.
Laemmli U. K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680–685.
Li W. W., Le Goascogne C., Ramaugé M., Schumacher M., Pierre M., and Courtin F. (2001) Induction of type 3 iodothyronine deiodinase by nerve injury in the rat peripheral nervous system. Endocrinology 142, 5190–5197.
Luca S., Saxe M., Gross C., Surget A., Battaglia F., Dulawa S., et al. (2003) Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805–809.
Manji H. K. and Lenox R. H. (1999) Protein kinase C signaling in the brain: molecular transduction of mood stabilization in the treatment of manic-depressive illness. Biol. Psychiatry 46, 1328–1335.
Manji H. K., Drevets W. C., and Charney D. S. (2001) The cellular neurobiology of depression. Nat. Med. 7, 541–547.
McEwen B. S. (1999) Stress and hippocampal plasticity. Annu. Rev. Neurosci. 22, 105–122.
McKnight S. G. (1977) A colorimetric method for the determination of submicrogram quantities of protein. Anal. Biochem. 78, 86–92.
Mercier G., Turque N., and Schumacher M. (2001) Early activation of transcription factor expression in Schwann cells by progesterone. Mol. Brain Res. 97, 137–148.
Murga C., Fukuhara S., and Gutkind J. S. (1999) Novel molecular mediators in the pathway connecting G-protein-coupled receptors to MAP kinase cascades. Trends Endocrinol. Metab. 10, 122–127.
Newman M. E., Agid E., Gur E., and Lerer B. (2000) Pharmacological mechanisms of T3 augmentation of antidepressant action. Int. J. Parmacol. 3, 187–191.
Nibuya M., Morinobu S., and Duman R. S. (1995) Regulation of BDNF and trkB mRNA in rat brain by chronic electrocon vulsive seizure and antidepressant drug treatments. J. Neurosci. 15, 7539–7547.
Nibuya M., Nestler E. J., and Duman R. S. (1996) Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus. J. Neurosci. 16, 2365–2372.
Pallud S., Gavaret J. M., Lennon A. M., Munsch N., St-Germain D. L., Pierre M., and Courtin F. (1999) Regulation of type 3 iodothyronine deiodinase expression in cultured rat astrocytes: role of the Erk cascade. Endocrinology 140, 2917–2924.
Russo-Neustadt A., Beard R. C., and Cotamn C. W. (1999) Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression. Neuropsychopharmacology 21, 679–682.
Smith M. A., Makino S., Kvetnansky R., and Post R. (1995). Effects of stress on neurotrophic factor expression in the rat brain. Ann. NY Acad. Sci. 771, 234–239.
Tan Y., Rouse J., Zhang A., Cariati S., Cohen P., and Comb M. J. (1996) FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J. 15, 4629–4642.
Tao X., Kinkbeiner S., Arnold D. B., Shaywitz A. J., and Greenberg M. E. (1998) Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20, 709–726.
Tu H. M., Legradi G., Bartha T., Salvatore D., Lechan R. M., and Larsen P. R. (1999) Regional expression of the type 3 iodothyronine deiodinase messenger ribonucleic acid in the rat central nervous system and its regulation by thyroid hormone. Endocrinology 140, 784–790.
Ullian E. M., Sapperstein S. K., Christopherson K. S., and Barres B. A. (2001) Control of synapse number by glia. Science 291, 657–660.
Yuan P. X., Huang L. D., Jiang Y. M., Gutkind S., Manji K. H., and Chen G. (2001) The mood stabilizer valproic acid activates mitogen-activated protein kinases and promotes neurite growth. J. Biol. Chem. 276, 31674–31683.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mercier, G., Lennon, A.M., Renouf, B. et al. MAP kinase activation by fluoxetine and its relation to gene expression in cultured rat astrocytes. J Mol Neurosci 24, 207–216 (2004). https://doi.org/10.1385/JMN:24:2:207
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/JMN:24:2:207